The current study provided a preliminary investigation of the connection between sleep disruptions and OSA using an objective home sleep test and biomarkers of early AD pathology (PET Aβ and tau) and AD symptomatology (cognitive impairments and depressed mood symptoms). Here, MAPT is linked to Alzheimer disease.